Efficacy and Safety of Cold Forceps Biopsy for Diminutive Pharyngolaryngeal Neoplasms

Efficacy and Safety of Cold Forceps Biopsy for Diminutive Pharyngolaryngeal Neoplasms - CFB-PLANS trial

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000033317

Enrollment

Registered

2018-07-07

Start date

2018-07-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pharyngolaryngeal neoplasias

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patient with diminutive pharyngolaryngeal neoplasias diagnosed using upper endoscopy within 1 year. 2. Cessation of antithrombotic agents according to the guideline of JSGE. 3. Consent for follow-up endoscopy over 3 months after treatment.

Exclusion criteria

Exclusion criteria: 1. Bleeding tendency (PLT <80000ul, PT-INR >2.5). 2. Pregnancy or breast feeding.

Design outcomes

Primary

Measure	Time frame
Endoscopic local recurrence rate 3 months after treatment	—

Secondary

Measure	Time frame
Complete resection rate, Pathological local recurrence rate 3 months after treatment, Endoscopic and Pathological local recurrence rate 12 months and 36 months after treatment, The rate of perioperative and postoperative bleeding	—

Countries

Japan

Contacts

Public ContactYuichi Shimodate

Kurashiki Central Hospital Gastroenterology and Hepatology

ys13544@kchnet.or.jp0864220210

Outcome results